Analysis scripts for SEND data would be valuable tools. Can existing clinical scripts be used to help develop Nonclinical scripts? What is the best process for prioritising, developing and releasing analysis scripts for SEND data?

Project Leads:

William Houser - william.houser@bms.com

Kevin Synder - kevin.snyder@fda.hhs.gov